Individuals with high risk of LS based on tumour tests (here and below, dMMR/MSI, plus BRAF V600E and/or MLH1 promoter hypermethylation tests where needed) should be referred for genetic counselling and germline genetic testing as appropriate. The gene discussed is BRAF; the disease is neoplasm.